Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03742258
Title Combination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Diffuse Large B Cell Lymphoma
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Northwestern University
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.